Grants paid by Moonshots for Unicorns
EIN 88-2730106 · Berkeley, CA · Form 990, Schedule I · NTEE U50
Moonshots for Unicorns of Berkeley, CA (EIN 88-2730106) reported 4 grants paid totaling $239,391 to 2 recipients in tax years 2022–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$239,391
4 grants
Recipients
2
distinct organizations
Tax years
2022–2024
3 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2022 | 2 | $140,952 | — |
| 2023 | 1 | $61,984 | — |
| 2024 | 1 | $36,455 | — |
Top recipients
The 2 recipients receiving the most from Moonshots for Unicorns, by grants paid, out of 2 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Nationwide Children's Hospital Research Institute 31-6056230 | A | Columbus, OH | 3 | $224,391 | 2024 |
| Perlara Pbc 46-5080858 | A | San Francisco, CA | 1 | $15,000 | 2022 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 4 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Nationwide Children's Hospital Abigail Wexner Research Institute Colombus, OH | A | $36,455 | paid | $31,455 of this grant supported optimizing the experimental gene therapy vector for PGAP3-CDG and testing it in patient induced neuron cell lines, as well as testing several small molecule potential therapies on those advanced cell lines. $5000 of this grant went to licensing the IP for all research completed at Nationwide Children's Hospital to Moonshots for Unicorns, as the principal investigator involved in this research left the institution. This enabled us to continue the research and advance its progress toward a clinical trial at other institutions. | 202541069349300709 |
| 2023 | Nationwide Children's Hospital Research Institute Columbus, OH | A | $61,984 | paid | This grant supported research aimed at creating an effective gene therapy to cure the monogenic disorder PGAP3-CDG, including testing it on mice and patient cells. | 202400929349300900 |
| 2022 | Nationwide Children's Hospital Research Institute Columbus, OH | A | $125,952 | paid | This grant was made to support research aimed a creating an effective gene therapy to cure the monogenic disorder PGAP3-CDG. | 202331109349300128 |
| 2022 | Perlara Pbc San Francisco, CA | A | $15,000 | paid | This grant supported drug repurposing research aimed at curing the monogenic disorder PGAP3-CDG. The money supported creation and characterization of PGAP3 knockout yeast and testing of existing medications on those yeast. | 202331109349300128 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2024 | 2024-12-31 | not stated | 2024v5.0 | 202541069349300709 |
| 990 | 2023 | 2023-12-31 | not stated | 2023v5.0 | 202400929349300900 |
| 990 | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202331109349300128 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/882730106.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.